Investors who have suffered losses can register their claims for this company on the Sina Investor Rights Protection Platform: http://wq.finance.sina.com.cn/ On January 14, 2026, the Hainan Securities Regulatory Bureau issued an administrative penalty decision ( [2026] No. 1 ) to Hainan Puli Pharmaceutical Co., Ltd. (hereinafter referred to as "Puli Pharmaceutical" or "the Company") and Fan Minhua. The company was penalized for failing to disclose its 2024 annual report within the statutory timeframe, resulting in an order for corrective actions, a warning, and a fine of 500,000 yuan; former Chairman and General Manager Fan Minhua was fined 200,000 yuan for failing to fulfill her duties with due diligence. Lawyer Zhao Jingguo (Practicing Certificate No.: 13101200410820485) of Shanghai Xinben Law Firm indicated that investors who purchased shares between April 26, 2022, and April 16, 2024, and held them, regardless of whether they sold the shares on or after April 17, 2024, may voluntarily register their claims through the "Sina Investor Rights Protection Platform."
On the same day, due to their failure to fulfill their duties with due diligence, Luo Tongning and Zhou Mao were held responsible for Puli Pharmaceutical's information disclosure violation of not disclosing the 2024 annual report on schedule. The Hainan Securities Regulatory Bureau took administrative supervisory measures against them, issuing warning letters, with the relevant records being entered into the capital market integrity database.
The Xinben Investor Claims Team reminds the public that as Puli Pharmaceutical has already been subjected to administrative penalties, investors who have suffered losses as a result can voluntarily register their claims through the "Sina Investor Rights Protection Platform."
Criteria for Claim Eligibility: Puli Pharmaceutical: According to relevant judicial interpretations, investors who meet the following criteria may initiate claims: those who purchased shares between April 26, 2022, and April 16, 2024, and held them, regardless of whether they sold the shares on or after April 17, 2024. (Note: The specific compensation scope will be ultimately determined by the court.)
(This article was contributed by Lawyer Zhao Jingguo, a partner at Shanghai Xinben Law Firm, and does not represent the views of Sina Finance. Lawyer Zhao Jingguo obtained his lawyer qualification in 1999, possesses a solid theoretical foundation in legal knowledge, and previously taught at a university. He began practicing law in 2004 and has handled over a thousand various litigation cases, accumulating extensive experience in dispute resolution, with particular expertise in securities disputes, finance, non-performing assets, and related matters. To date, Lawyer Zhao Jingguo has represented investors in claims against multiple listed companies, with cases that have already been won or compensated including claims against Zhonganke, Zhongbing Hongjian, Busen Apparel, Zhongqian Shares, Aruide, Zhangzi Island, Tianyu Entertainment, Fushun Special Steel, Feile Acoustics, Xiangyi Finance, Yan'an Bikang, Huanrui Century, Zijing Storage, Zeda Easyshare, Annie Co., Ltd., among others.)